
NIH-Funded Breakthrough Shrinks CRISPR for Precision In-Vivo Delivery
An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enabling precise in-vivo gene editing...
Read Full Story →Explore our comprehensive coverage of gene editing, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enabling precise in-vivo gene editing...
Read Full Story →
BusinessScientists have developed a new CRISPR technique that can activate genes by removing chemical tags w...
Medical ResearchScientists have developed a new CRISPR technique that can activate genes by removing chemical tags w...
Medical ResearchIn a landmark medical achievement, the first in-vivo CRISPR gene-editing therapy has successfully an...
BusinessOxford University and CRISPR Therapeutics have achieved the first functional cure for Type 1 Diabete...
Medical ResearchOxford University and CRISPR Therapeutics have achieved the first functional cure for Type 1 Diabete...
BusinessVerve Therapeutics' in vivo CRISPR base editing program, VERVE-102, utilizes lipid nanoparticles to ...